Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 250 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2422 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
25 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1790 |
RATIO-NYSTATIN | 100000UNIT | CREAM | Resolved | 2017-03-13 | 2020-02-13 | 1739 |
RATIO-SALBUTAMOL | 0.5MG | SOLUTION | Resolved | 2017-03-14 | 2020-02-13 | 2419 |
TEVA-TERBINAFINE | 250MG | TABLET | Actual shortage | 2017-03-13 | 2020-02-13 | 1655 |
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1697 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 997 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1001 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1009 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1006 |
EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1694 |
LINEZOLID INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1711 |
EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1691 |
VINCRISTINE SULFATE INJECTION | 1MG | SOLUTION | Resolved | 2019-11-07 | 2020-02-21 | 98179 |
DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-01-09 | 2020-02-21 | 102893 |
TEVA-TOPISONE | .05% | CREAM | Resolved | 2020-01-24 | 2020-02-21 | 104362 |
TEVA-COTRIDIN | 30MG 2MG 10MG | SYRUP | Resolved | 2020-01-30 | 2020-02-21 | 104911 |
TEVA-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-02-13 | 2020-02-21 | 106012 |
ACT ESCITALOPRAM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99971 |
ACT ESCITALOPRAM ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-11-28 | 2020-02-21 | 99974 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |